AI Patent Analysis Toolkit
PatentAgility
by KellDann

Examiner Manahil Mirghani Ali Abdalhameed

Examiner Manahil Mirghani Ali Abdalhameed appears to be about average relative to their peer examiners. Their lifetime grant ratio is 30.8%, they average 1.77 office actions per granted patent, and their rejection profile is dominated by ยง103.

Difficulty vs AU Very Hard
Difficulty vs Group Very Hard
Difficulty vs TC About Average
Difficulty vs USPTO About Average
Average OA / Grant 1.77
Export
Word PDF

Create account to export.

Examiner Details

Observed Examiner Years
5 years (2022-2026)
Phone
(571) 272-1242
Predicted Supervisor
James H Alstrum-Acevedo
Supervisor Phone
(571) 272-5548
Tech Center
1600 - Biotechnology and Organic
Group
1620 - Biomedicinal Chemistry

Metrics

Applications Evaluated
172
Granted Applications
53
Non-Granted Applications
119
Avg OA / Grant
1.77
Last OA Observed
March 2026 (0 months ago)
Art Units Seen
1622 , 1629
Work Groups Seen

Context Comparison

Scope Examiners Lifetime Grant Ratio Avg OA / Grant
This Examiner 1 30.8% 1.77
Art Unit 17 43.4% 1.68
Group 248 48.3% 1.76
Tech Center 1,349 39.5% 2.02
USPTO 16,116 54.8% 1.98

Grant Timeline

0.0% 25.0% 50.0% 75.0% 100.0% 2022 2023 2024 2025 2026
Shaded region marks the last two observed years, where grant outcomes may lag due to recency.
Year Applications Granted Grant Rate
No observed data before 2022; examiner may not yet have been active in the available dataset.
2022 8 4 50.0%
2023 38 18 47.4%
2024 41 20 48.8%
2025 64 11 17.2%
2026 21 0 0.0%

53 family-cache-validated grants; 0 OA-only grant signals.

Rejection Timeline

OA # Office Actions § 101 Percentage § 102 Percentage § 103 Percentage § 112 Percentage
1 157 1.3% 7.6% 47.1% 2.5%
2 87 0.0% 10.3% 59.8% 2.3%
3 48 0.0% 2.1% 54.2% 4.2%
4 26 0.0% 19.2% 57.7% 7.7%
5 13 0.0% 7.7% 61.5% 0.0%
6 6 0.0% 0.0% 66.7% 0.0%
7 3 0.0% 0.0% 66.7% 0.0%
8 2 0.0% 0.0% 100.0% 0.0%

§ 101 Yearly Trend

2024: AI Examples
2025: Aug. Memo
0.0%
2022
1.0%
2023
0.0%
2024
1.0%
2025
0.0%
2026

Each bar shows the share of this examiner's observed office actions in that year that included a § 101 rejection.